Combinatorial immunotherapy for melanoma
Melanoma has been a long-standing focal point for immunotherapy development. In this review, we explore the evolution of melanoma treatments with particular attention to the history and recent advances in melanoma immunotherapy. We also discuss novel combinations of these modalities and their potential to offer novel therapeutic options for patients with advanced melanoma.
Cancer Gene Ther 2017; 24: 141–147. doi:10.1038/cgt.2016.56